Oxford At least for severe cases of Covid-19, there is now hope. The drug is cheap and readily available. The anti-inflammatory drug dexamethasone reduces demonstrably the mortality of Covid-19-patients.
The world health organization has welcomed the preliminary findings of a British study of a drug for the lung disease Covid-19 as a breakthrough. In the case of the anti-inflammatory drug dexamethasone was the first agent that the mortality of Covid-19-reduce patients who were dependent on oxygen or ventilators, said the WHO chief Tedros Adhanom Ghebreyesus of a message by Tuesday evening, according to.
“This is great news,” said Tedros accordingly. “I congratulate the government of the United Kingdom, the University of Oxford, as well as the many hospitals and patients in the United Kingdom, who have contributed to this life-saving scientific breakthrough.”
The preliminary results, as yet unpublished clinical study indicates that dexamethasone could reduce the mortality rate in severe Covid-19-gradients. Patients were artificially ventilated, and the drug received, the mortality rate decreased by one-third, as the leading scientists of the University of Oxford on Tuesday reported in a press release. The results of the “Recovery”study, but has not been previously reviewed by other experts.
In the study, scientists investigate the Suitability of already approved drugs as a means of counter-Covid-19. In total, more than 11,500 patients from over 175 clinics in the UK are reported to be included in the study. The dexamethasone part of the study included, therefore, 2104 patients were given for ten days once a day 6 milligrams of dexamethasone. 4321 patients served as a control group.
The mortality rate after 28 days was below the artificially ventilated patients is the highest. It was without dexamethasone treatment at 41 percent. In the experimental group, it decreased by a third. In the case of the patient, the oxygen got, but not artificially ventilated, it decreased by a fifth. In the patients, which required no oxygen, showed the treatment to have no effect.
Based on the Numbers would be prevented in the treatment of eight seriously ill Covid-19 patients by dexamethasone-a case of death, it said. The drug is commonly used as anti-inflammatory agents, including inflammation of the skin and joints.
In patients who required a ventilator and dexamethasone were given, decreased the mortality rate to 35 per cent, and for those that need only additional oxygen to 20 percent. In less severely ill patients, dexamethasone seemed to have no positive effects.
The results of the study showed a clear and great positive impact on the survival rate of patients who are so sick that they need oxygen treatment, said Peter Horby of the University of Oxford, one of the conductors of the study. “So dexamethasone should be now the Standard treatment of these patients,” he said. The drug is cheap, available and could be used immediately to save lives around the world.
Nick Cammack, of the British charity Wellcome requested that dexamethasone would have to be Thousands made sick Heavy available worldwide. Although it will help only in severe cases, it’ll save countless lives.
Steroids are anti-inflammatory, which can help Covid-19-patient whose immune system in the fight against the corona of infection overreacted. Because this can have fatal consequence, put Doctors in such cases, steroids and other anti-inflammatories. The world health organization, WHO, has, however, warned of steroids in an early stage of the disease, because they could slow down the healing as a whole.
The study had revealed a few days ago that the US President Donald Trump always advertised antimalarials hydroxychloroquine against Covid-19 has no significant effect. The research examines other treatment options a corona of infection, and is funded by the British government and private donors, including the Bill and Melinda Gates Foundation.